Showing results (311-320 of 992) with videos related to
Sort By:
Pageof 100
Journal of Opioid Management|September 5, 2025
Population-based prescription opioid use rate in Newfoundland and Labrador: A retrospective cohort studyCindy Whitten, Alison Turner, Kobe Roberts, et al.Journal of Opioid Management|September 4, 2025
Opioid use in impending versus pathologic proximal femur fracturesAustin Yu, Conor M Jones, Gayathri Vijayakumar, et al.Journal of Opioid Management|September 4, 2025
Implementation of opioid stewardship programs (OSPs) in hospitals: A narrative literature reviewBridget S Murphy, Nicole FallsJournal of Opioid Management|May 19, 2020
Factors associated with participation and nonparticipation in a VA Whole Health Primary Care Pain Education and Opioid Monitoring Program (PC-POP)Amber Martinson, Amanda Kutz, William Marchand, et al.Journal of Opioid Management|July 21, 2016
Fentanyl in a pectin gel treating breakthrough pain in vertebral compression fracture due to multiple myeloma: A descriptive study of three casesBorja Mugabure Bujedo, Brynjar KarlssonJournal of Opioid Management|February 24, 2007
Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians' attitudesMarc K Bendiane, Patrick Peretti-Watel, Herve Pegliasco, et al.Journal of Opioid Management|February 24, 2007
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristicsKyriaki Mystakidou, Emmanuela Katsouda, Efi Parpa, et al.Journal of Opioid Management|February 24, 2007
Establishing the safety and efficacy of an opioid titration protocolNancy Wells, Barbara Murphy, Stacey Douglas, et al.Journal of Opioid Management|February 24, 2007
The metamorphosis of hydromorphoneGary M Reisfield, George R WilsonJournal of Opioid Management|February 24, 2007
A descriptive case series: oral transmucosal fentanyl use in patients with noncancerous painAnthony H Guarino, Jennifer Myers, Martha E CornellPageof 100